Yorkville Advisors

Yorkville Advisors Global, LLC is a privately owned hedge fund sponsor established in 2001 and headquartered in Mountainside, New Jersey, with additional offices in Palm Beach Gardens, Florida; Denver, Colorado; Milan, Italy; and Hong Kong. The firm specializes in providing specialty financing solutions, primarily through structured debt and equity investments, with a focus on growth companies across various industries. Yorkville Advisors employs a combination of technical and fundamental analysis to identify investment opportunities, often acting as a sole investor in capital raises to ensure a controlled exit strategy. The firm's investment strategy spans public equity, fixed income, and alternative investment markets globally, with particular emphasis on sectors such as healthcare, metals and mining, energy, technology, and electric vehicles. Each investment is tailored to meet the specific needs of the companies involved, reflecting Yorkville's commitment to supporting growth and acquisition capital for public companies.

Mark Angelo

President and Partner

Past deals in North Dakota

ImmunoPrecise Antibodies

Post in 2024
ImmunoPrecise Antibodies Ltd. is a biotherapeutic research and technology company specializing in the production of custom antibodies and related services. Headquartered in Fargo, North Dakota, the company operates in the United States, Canada, Europe, and internationally. Its extensive service offerings include B cell sorting, phage display production, transgenic animal models, and various antibody engineering techniques. The company has developed a reputation for its advanced capabilities in antibody discovery and development, leveraging systems biology, multi-omics modeling, and artificial intelligence to enhance efficiency and accuracy. ImmunoPrecise Antibodies engages in collaborations with academic and research institutions, including partnerships aimed at developing antibody-based tests for COVID-19 and neutralizing antibodies against SARS-CoV-2. Founded in 1989, the company continues to contribute to the advancement of novel biologics and therapeutic solutions for challenging diseases.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.